Advertisement
U.S. Markets open in 8 hrs 53 mins
S&P Futures
5,887.75 -4.75 (-0.08%) Dow Futures
43,048.00 -121.00 (-0.28%) Nasdaq Futures
20,517.00 -25.00 (-0.12%) Russell 2000 Futures
2,243.70 -2.50 (-0.11%) Crude Oil
72.24 +0.15 (+0.21%) Gold
2,763.10 +3.30 (+0.12%)
Hua Medicine (Shanghai) Ltd. (2552.HK)
HKSE - HKSE Delayed Price. Currency in HKD
Follow
As of 11:58AM HKT. Market open.
Currency in HKD
Valuation Measures4
| Market Cap (intraday) | 1.50B |
| Enterprise Value | 334.30M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 12.58 |
| Price/Book (mrq) | 10.50 |
| Enterprise Value/Revenue | 2.80 |
| Enterprise Value/EBITDA | -11.55 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.56 |
| 52-Week Change 3 | N/A |
| S&P500 52-Week Change 3 | N/A |
| 52 Week High 3 | 2.650 |
| 52 Week Low 3 | 1.030 |
| 50-Day Moving Average 3 | 1.252 |
| 200-Day Moving Average 3 | 1.518 |
Share Statistics
| Avg Vol (3 month) 3 | 1.76M |
| Avg Vol (10 day) 3 | 2.91M |
| Shares Outstanding 5 | 981.12M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 631.02M |
| % Held by Insiders 1 | 13.64% |
| % Held by Institutions 1 | 33.76% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in CNY.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Jun 30, 2024 |
Profitability
| Profit Margin | -241.76% |
| Operating Margin (ttm) | -189.19% |
Management Effectiveness
| Return on Assets (ttm) | -17.81% |
| Return on Equity (ttm) | -300.57% |
Income Statement
| Revenue (ttm) | 108.94M |
| Revenue Per Share (ttm) | 0.11 |
| Quarterly Revenue Growth (yoy) | 46.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | -382.94M |
| Net Income Avi to Common (ttm) | -263.38M |
| Diluted EPS (ttm) | -0.310 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.34B |
| Total Cash Per Share (mrq) | 1.37 |
| Total Debt (mrq) | 272.41M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.87 |
| Book Value Per Share (mrq) | -0.03 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 403.82M |
| Levered Free Cash Flow (ttm) | -196.16M |
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.